2021. 2020 consensus guideline for optimal approach to the diagnosis and treatment of HER2-positive breast cancer in Bosnia and Herzegovina. Biomolecules and Biomedicine. 21, 2 (Apr. 2021), 120–135. DOI:https://doi.org/10.17305/bjbms.2020.4846.